We use cookies to personalise the website and offer you the greatest added value. They are, among other purposes, used to analyse visitor usage in order to improve the website for you. By using this website, you agree to their use. Further information can be found in our data privacy statement.

Rödl & Partner advises PharmaLex on its merger with BioStat Solutions, Inc.


Atlanta, Georgia, October 22, 2020: Rödl & Partner advised PharmaLex Group on its merger with BioStat Solutions, Inc. (BSSI), which specializes in data analytics including statistical and bioinformatics and a focus on biomarker research, drug target identification / prioritization and complex drug, biologic and medical device studies and interpretation.

Rödl & Partner's U.S. transaction services-team led by Frank Breitenfeldt acted as the exclusive financial advisor to PharmaLex Group. Key service areas included buy-side financial and tax due diligence, deal advisory and purchase contract drafting assistance. The transaction was completed on Sep 16, 2020.

The transaction is expected to strengthen the joint statistical solutions service offerings. The BSSI service portfolio is expected to complement the PharmaLex Group’s line-up via increased focus on Bayesian statistics and further tapping into the growing biomarker and bioinformatics market, which are both expected to grow with >13% per annum, according to Dr. Thomas Dobmeyer, CEO PharmaLex.

About PharmaLex

PharmaLex is a leading provider of specialized services for the pharma, biotech and medical device industries. They guide from early strategic planning activities and non-clinical requirements through clinical development, regulatory submission processes and post-approval / maintenance post-launch activities. Their experts use technology-enabled solutions to support services throughout the entire product lifecycle – going above and beyond the standard to deliver tailor-made solutions worldwide.
The PharmaLex Group now has over 1000 employees, with 33 offices in 21 countries and more than 600 satisfied clients worldwide.

Advisors to PharmaLex

Rödl & Partner USA (Rödl Langford de Kock LP)

Frank Breitenfeldt, Partner (Transaction Services), Atlanta, project lead – Financial
Dennis Wieckert, Senior Principal (M&A Tax), Atlanta – Tax
Christian Haverney, Associate Partner (Transaction Services), Atlanta – Financial & Tax
Olivier Toubon, Senior Associate (Transaction Services), Atlanta – Financial


Frank Breitenfeldt


Partner, German Speaking

+1 404 525 2600

Send inquiry


Contact Person Picture

Christian Haverney


Associate Partner, German Speaking

+1 404 525 2600

Send inquiry


Contact Person Picture

Deutschland Weltweit Search Menu